FDA Inspection 1225778 — KONAD Co., Ltd.
The FDA completed an inspection of KONAD Co., Ltd. on Nov 10, 2023 in Namdong. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 10, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Namdong (Korea (the Republic of))